| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMN | Common Stock | Options Exercise | $0 | +1.33K | +26.43% | $0.00 | 6.34K | Jan 3, 2022 | Direct | F1 |
| transaction | AMN | Common Stock | Tax liability | -$65.3K | -534 | -8.42% | $122.33 | 5.81K | Jan 3, 2022 | Direct | F2 |
| transaction | AMN | Common Stock | Options Exercise | $0 | +2.28K | +39.32% | $0.00 | 8.09K | Jan 4, 2022 | Direct | F1 |
| transaction | AMN | Common Stock | Tax liability | -$95.1K | -787 | -9.72% | $120.80 | 7.31K | Jan 4, 2022 | Direct | F2 |
| transaction | AMN | Common Stock | Award | $0 | +4.41K | +60.32% | $0.00 | 11.7K | Jan 4, 2022 | Direct | F3 |
| transaction | AMN | Common Stock | Tax liability | -$184K | -1.52K | -13.01% | $120.80 | 10.2K | Jan 4, 2022 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMN | Restricted Stock Units | Options Exercise | $0 | -1.33K | -100% | $0.00* | 0 | Jan 3, 2022 | Common Stock | 1.33K | Direct | F4, F5, F6 | |
| transaction | AMN | Restricted Stock Units | Options Exercise | $0 | -2.28K | -32.99% | $0.00 | 4.64K | Jan 4, 2022 | Common Stock | 2.28K | Direct | F4, F6, F7 |
| Id | Content |
|---|---|
| F1 | Common Stock acquired on the vesting of Restricted Stock Units. |
| F2 | Number of shares withheld for tax purposes. |
| F3 | The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2018 for the 3-year period beginning on January 1, 2019 and ended December 31, 2021 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2022. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested. |
| F4 | The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. |
| F5 | The Restricted Stock Units identified in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. |
| F6 | Restricted Stock Units do not have an expiration date. |
| F7 | The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. |